IP Library Granted Patent US 9,974,479
Granted Patent B2
US 9,974,479 · App. 15/186,726 · Granted May 22, 2018

Monitoring asthma and other respiratory disorders with calibrated photoplethysmography devices and methods of using the same

Inventor: Richard J. Melker (Gainesville, FL)
Assignee: University of Florida Research Foundation, Inc.
A61B5/4884A61B5/0205A61B5/08A61B5/14551A61B5/411A61B5/4836A61M16/0069A61M16/1005A61B5/02416A61B5/085A61B5/1073A61B5/14552A61B2560/0223A61M2205/3303A61M2205/3306A61M2205/502A61M2230/205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,974,479
App. No.
15/186,726
Granted
May 22, 2018
Kind
B2
Abstract

Provided according to embodiments of the invention are methods of monitoring air obstruction in an individual that include obtaining at least one calibration photoplethysmography (PPG) signal stream from the individual while the individual spontaneously breathes through at least one resistor having a known resistance; using a processing device to determine changes in the at least one calibration PPG signal stream in response to an increase in resistance to the individual's breathing; obtaining a monitoring PPG signal stream from the individual during spontaneous breathing; and using the monitored PPG signal stream to determine a calibrated resistance value, and using the calibrated resistance value to determine a level of obstruction of the individual's breathing. Related devices are also provided herein.

Claims (24)

1. A method of monitoring air obstruction in an individual, comprising

(a) obtaining at least one calibration photoplethysmography (PPG) signal stream from the individual while the individual spontaneously breathes through at least one resistor having a known resistance;

(b) using a processing device to determine changes in the at least one calibration PPG signal stream in response to an increase in resistance to the individual's breathing;

(c) obtaining a monitoring PPG signal stream from the individual during spontaneous breathing; and

(d) using the monitored PPG signal stream to determine a calibrated resistance value, and using the calibrated resistance value to determine a level of obstruction of the individual's breathing.

2. The method of claim 1 , wherein the at least one calibration PPG signal stream and the monitoring PPG signal stream are isolated pulsatile arterial component (PAC) signal streams.

3. The method of claim 2 , wherein exhalation PAC signals decrease as air obstruction in the individual increases.

4. The method of claim 2 , wherein inhalation PAC signals increase as air obstruction in the individual increases.

5. The method of claim 1 , wherein the at least one calibration PPG signal stream and the monitoring PPG signal stream are isolated venous impedance component (VIC) signal streams.

6. The method of claim 5 , wherein exhalation VIC signals increase as air obstruction in the individual increases.

7. The method of claim 5 , wherein inhalation VIC signals decrease as air obstruction in the individual increases.

8. The method of claim 1 , wherein the individual is determined to be partially or fully occluded if the monitored PPG signal stream corresponds to a calibrated resistance in a range of 20 to 40 cm H 2 O/L/s.

9. The method of claim 1 , wherein at least one calibration PPG signal stream is obtained while the individual takes a series of normal breaths followed by a series of breaths with resistors having different known levels of resistance.

10. The method of claim 1 , wherein the at least one calibration PPG signal stream and the monitoring PPG signal stream are obtained from a central source site.

11. The method of claim 1 , wherein the processing device is a hand-held device that comprises a readout screen that displays information regarding the level of obstruction in the individual.

12. The method of claim 1 , wherein the level of obstruction of the individual is used to monitor asthma in the individual.

13. The method of claim 1 , wherein the resistors only resist inspiratory or expiratory air flow.

14. A respiratory monitoring device, comprising a processor that

receives at least one calibration photoplethysmography (PPG) signal stream from an individual while the individual breathes through at least one resistor having a known resistance;

determines changes in the at least one calibration PPG signal stream in response to increases in resistance to the individual's breathing; and

uses a monitored PPG signal stream to determine a calibrated resistance value, and uses the calibrated resistance value to determine a level of obstruction of the individual's breathing.

15. The respiratory monitoring device of claim 14 , wherein the at least one calibration PPG signal stream and the monitored PPG signal stream comprise an isolated PAC signal stream, an isolated VIC signal stream, or both.

16. The respiratory monitoring device of claim 14 , wherein the at least one calibration PPG signal stream and the monitoring PPG signal stream are obtained from a central source site.

17. The respiratory monitoring device of claim 14 , wherein the device is a hand-held device that comprises a readout screen that displays information regarding the level of obstruction in the individual.

Continuity (4)
Continuation 14334114 · Jul 17, 2014
Continuation 11909004
Continuation In Part 11122278 · Apr 25, 2005
Related Publication 20170049391A1 · Feb 23, 2017